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Multiple  studies  have  demonstrated  that  telomere  length  predicts  mortality  and  that  telomeres  shorten
with  age.  Although  rarely  acknowledged  these  associations  do  not  dictate  causality.  I review  telomerase
knockout  and overexpression  studies  and  ﬁnd  little  support  that telomeres  cause  aging.  In addition,  the
causality  hypothesis  assumes  that  there  is  a critical  telomere  length  at  which  senescence  is  induced.  This
generates  the  prediction  that variance  in telomere  length  decreases  with  age. In  contrast,  using meta-eywords:
elomere length
ortality
pidemiology
eta-analysis
uman
analysis  of  human  data,  I ﬁnd  no  such  decline.  Inferring  the  causal  involvement  of  telomeres  in  aging
from  current  knowledge  is  therefore  speculative  and  could  hinder  scientiﬁc  progress.
©  2015  Z. Published  by  Elsevier  B.V.  This  is an  open  access  article  under  the CC  BY-NC-ND  license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).enescence
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. Introduction
(Riethman, 2008). Additional properties have made telomeres a
focus in the biology of aging: (i) telomeres shorten at each cell
division due to incomplete replication of their ends; (ii) theyPlease cite this article in press as: Simons, M.J.P., Questioning caus
http://dx.doi.org/10.1016/j.arr.2015.08.002
.1. Telomere biology
Telomeres are repetitive DNA sequences at the ends of lin-
ar chromosomes and serve to maintain chromosome integrity
E-mail address: mirresimons@gmail.com
ttp://dx.doi.org/10.1016/j.arr.2015.08.002
568-1637/© 2015 Z. Published by Elsevier B.V. This is an open access article under the Care shortened by oxidative damage; and (iii) when telomeres
reach a critical length, cells enter a senescent state and cell divi-
sion ceases. This latter property has been demonstrated in now
classic experiments, showing that telomere length predicts theal involvement of telomeres in aging. Ageing Res. Rev. (2015),
in vitro replicative capacity of human ﬁbroblasts and that over-
expressing telomerase—the enzyme that can reverse transcribe
telomeric sequence—immortalizes ﬁbroblast cell cultures (Bodnar
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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t al., 1998; Rudolph et al., 1999). These experiments suggest the
ossible causal involvement of telomeres in the aging process and
his hypothesis has increased in popularity since the ﬁnding that
elomere length predicts human mortality (Boonekamp et al., 2013;
awthon et al., 2003) and that, in vivo, human telomeres shorten
uring aging (Müezzinler et al., 2013).
.2. Association is not causality, and no causality without
ssociation
It is rarely acknowledged in telomere biology that such associ-
tions do not necessarily dictate causality. Of course in principle
ssociations can never show causality, and experimental evidence
s a starting point. However when epidemiological associations are
ery strong and are corroborated by experimental evidence from
nimals or other supporting evidence, such as in the relationship
etween smoking and lung cancer (Cornﬁeld et al., 2009), causality
an be deduced. Such inference is useful interpreting data in terms
f biological mechanism and for policy, but can also be harmful
hen such causality is prematurely inferred or assumed. This can
ead to reduced or misfocused research effort to uncover the mech-
nisms actually responsible for the associations that are reported
r false inference of the associated biology. In the biology of aging
t is tempting to infer causality from biomarkers of aging because
ging mechanisms remain so elusive. It is therefore not surprising
hat causality of telomere length in aging is often inferred from
ssociations or from the available experimental evidence.
Such inferences span different ﬁelds of biology working on
elomeres with the following quotes to illustrate this. Within
volutionary ecology: “When telomeres reach a critically short
ength. . .contributes to the decline in tissue function in later life”
Herborn et al., 2014). “..our study provides good evidence for a
echanistic link between telomere erosion and reduced organism
ongevity under natural conditions” (Bize et al., 2009). Mechanis-
ic research: “Genetically modiﬁed animal models have established
ausal links between telomere loss, cellular senescence, and organ-
smal aging” (López-Otín et al., 2013). “These ﬁndings demonstrate
hat short telomeres have a direct impact on longevity in mam-
als” (Vera et al., 2012). Epidemiology: “We  propose that telomere
ength is not only associated with atherosclerosis and longevity but
s also a causal determinant of both” (Aviv et al., 2015). Genetics:
Our ﬁndings support a causal role of telomere-length variation in
ome age-related diseases” (Codd et al., 2013). Psychiatry, reason-
ng from an association with telomere length: “..links of childhood
altreatment with psychopathology and associated medical prob-
ems could be due to effects of stress on cellular aging.” (Tyrka et al.,
010).
These quotes cannot objectively summarize the dominating
pinion in telomere biology, however they do highlight that causal-
ty is often deduced from the current literature. Here I question such
ausal involvement of telomeres in aging using a critical review
f the mechanistic evidence and a formal meta-analysis of a key
rediction when a causal link between telomeres and mortality is
ssumed.
. Results
.1. Mechanistic evidence
I review the telomerase knockout and overexpression studies
hat are often cited and hailed as providing the necessary evidencePlease cite this article in press as: Simons, M.J.P., Questioning caus
http://dx.doi.org/10.1016/j.arr.2015.08.002
or the causal involvement of telomere biology in aging. I collated
tudies on the effects on longevity and conclude that, together; the
esults are surprisingly mixed and provide weak support (Fig. 1).
n the cases where lifespan changed as predicted in response to PRESS
eviews xxx (2015) xxx–xxx
the manipulation of telomerase, the effect on telomere length was
either outside the normal range of telomere shortening or telom-
ere elongation was not conclusively demonstrated, thereby limiting
any strong conclusions. The conclusion that natural genetic vari-
ation in telomeres causes aging would need to be supported by
shortening manipulations that fall within the range seen across the
lifespan in unmanipulated individuals.
2.1.1. Mouse models
Mice in which telomerase has been knocked out show reduced
longevity, but this effect is only visible after multiple generations
(Espejel et al., 2004; Rudolph et al., 1999), suggesting that telomeres
have to become extremely short before they impinge on senescence
in vivo. Such critically short lengths might never be reached in a
normal mouse life. Telomerase knockout mice in generation 1, in
which there is very limited modulation of lifespan, already exhibit
severely shortened telomeres (Espejel et al., 2004; Rudolph et al.,
1999). Knocking out telomerase shortens telomere length by about
∼4–5 kb per generation (Blasco et al., 1997; Rudolph et al., 1999),
whereas ∼15 kb are lost over a wild-type mouse’s lifetime (Vera
et al., 2012). Thus when lifespan reduction does become apparent at
generation 3 and beyond, telomeres in these telomerase-deﬁcient
mice have shortened by about as much as over the entire life of a
normal mouse, yet these knock-out mice are still viable and their
telomeres continue to shorten substantially over their lives prior
to death (Rudolph et al., 1999). These results suggest that telome-
rase knockout models are not necessarily informative about the
involvement of telomeres in normal wild-type aging, but are per-
haps more appropriately seen as a model of telomerase-associated
diseases, such as dyskeratosis congenita (Mitchell et al., 1999).
Another ﬁnding that is often used as evidence for the causal
role of telomeres in aging is the fact that overexpressing telome-
rase in mice extends lifespan when selectively expressed at old age
(Bernardes de Jesus et al., 2012). However, effects on actual telom-
ere length are far from conclusive (Bernardes de Jesus et al., 2012).
Doubts about actual increased telomere length via telomerase over-
expression increase the possibility that the observed effects are
mediated by the actions of telomerase beyond actual telomere
length elongation (Cong and Shay, 2008). The sample sizes to ver-
ify telomere length elongation under telomerase overexpression
(Bernardes de Jesus et al., 2012) are very low (3 or 4 per group)
and the use of t-tests (that assume normality) over non-parametric
equivalents is likely to be inappropriate for comparing proportions,
such as the fraction of short telomeres that is often used as a mea-
sure. The lowest p value that can be reached with a sample of 3
per group using non-parametric alternatives is 0.05—the probabil-
ity that all three values from one group are lower than the other
by chance. This is strikingly different than some of the probabili-
ties (p < 0.01) reported using similar sample sizes using t-tests on
telomere length measures (Bernardes de Jesus et al., 2012), suggest-
ing a strong reduction in p values due to inappropriately assuming
normality. Moreover, the use of statistics on q-FISH data that treat
each cell as an independent measurement (Bernardes de Jesus et al.,
2012) is clearly incorrect and severely biased due to pseudorepli-
cation, because the independent statistical unit is the individual
mouse. In general, the causal contribution of telomeres to aging in
inbred strains of laboratory mice can be questioned because these
animals show markedly longer telomeres than their wild or out-
bred relatives, without living longer (Hemann et al., 2001; Miller
et al., 2002). In a comparative context absolute length of telomeresal involvement of telomeres in aging. Ageing Res. Rev. (2015),
is actually inversely related to lifespan in mammals, with the short-
est telomeres amongst the longest-lived species, such as whales
(Gomes et al., 2011). In addition, the claim that a drug, TA-65,
increases telomere length, but does not affect overall mortality, also
ARTICLE IN PRESSG ModelARR-600; No. of Pages 6
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Fig. 1. Overview of the mechanistic evidence for a causal link between telomere length and longevity. Telomerase is the enzyme responsible for elongating telomeres. Con-
sequently, a knockout of telomerase is expected to decrease longevity, whereas conversely overexpression is expected to increase longevity. Although telomere maintenance
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n  the comments in the ﬁgure, refer to the main text.
ontradicts a direct causal relationship between telomere length
nd mortality (de Jesus et al., 2011).
.1.2. Other model species
Not only are studies on mice inconclusive, studies on other
pecies also cast doubt on the universal causal involvement of
elomeres in aging. Recently, telomerase-mutant zebra ﬁsh were
hown to have strikingly shortened lifespans, but again the level
f telomere attrition seen in these mutants is markedly higher
han in old wild-type animals (Henriques et al., 2013), suggest-
ng that the phenotype might not be representative of normal
ging. Furthermore, telomerase-mutant Arabidopsis does not show
 senescent phenotype and, despite developmental abnormalities,
utlives wild-type plants (Fitzgerald et al., 1999; Riha et al., 2001).
ongevity can also be uncoupled from telomere length in Drosophila
Walter et al., 2007) and in Caenorhabditis elegans (Meier et al.,
006; Raices et al., 2005) any life-extending effects of long telom-
res are dependent on daf-16 signaling. Thereby demonstrating
hat this phenotype in C. elegans is not due to the negative mechan-
cal consequences of critically short telomeres, but dependent on
ownstream molecular signaling pathways (Joeng et al., 2004).
.1.3. Conclusion from current mechanistic evidence
From these studies I conclude that either telomeres are not
ausal in aging or, at least, that the underlying mechanisms are
ot universal, making unreliable any direct inference of causality
rom these model species to human biology. The recent ﬁnding that
elomeres regulate DNA damage responses, independent of actual
elomere length, questions further the role of telomere mainte-
ance in cellular senescence (Fumagalli et al., 2012; Hewitt et al.,Please cite this article in press as: Simons, M.J.P., Questioning caus
http://dx.doi.org/10.1016/j.arr.2015.08.002
012). Cell cycle progression is arrested when DNA-damage is not
epaired, and persistent DNA-damage response foci are associated
ith cellular senescence. Such persistent DNA-damage response
oci were found to be strongly localized at telomeres in human cellround ‘telomerase’) it is clear that effects on longevity are not universal and mixed.
N/A indicates that no study is available for this comparison. For further elaboration
culture (Fumagalli et al., 2012; Hewitt et al., 2012) and increase with
age in mouse liver and gut (Hewitt et al., 2012), and importantly,
these effects are independent of the actual length of these telom-
eres (Fumagalli et al., 2012; Hewitt et al., 2012). This suggests that
telomeres are signaling the current and past level of DNA-damage
irrespective of their length, at odds with the assumption that critical
shortening of telomeres causes cellular senescence.
2.2. Critical tests of causality using epidemiological evidence
2.2.1. The association of telomere length and mortality reduces
with age
Epidemiological studies have demonstrated the associations
between telomere length and mortality or disease, but epidemi-
ological data also provide the opportunity to test the predictions
that follow from the causal involvement of telomeres in aging. For
instance, if telomere length determines mortality at old age, then
there is a clear expectation that telomere length will more closely
predict remaining lifespan at older versus younger ages. How-
ever, telomere length does not predict mortality in the very oldest
(Bischoff et al., 2006; Martin-Ruiz et al., 2005) and a meta-analysis
across the available literature has conﬁrmed that the association
between telomere length and overall mortality actually diminishes
with age (Boonekamp et al., 2013).
2.2.2. Variance in telomere length should decline with age
Here, I test another speciﬁc prediction of the current hypoth-
esis concerning the involvement of telomere length in aging
(Blasco, 2007, 2005): there will be a critical length at which telom-
eres induce cellular senescence, aging and eventually death. Suchal involvement of telomeres in aging. Ageing Res. Rev. (2015),
a critical length of telomeres leads to the previously unrecog-
nized prediction that variance in telomere length should strongly
decrease with age. The individuals with the shortest telomeres
would die off when their telomeres reached critically short lengths.
ARTICLE ING ModelARR-600; No. of Pages 6
4 M.J.P. Simons / Ageing Research R
age (years)
40 50 60 70 80 90
ln
 (S
D 
TL
)
-1.0
-0.8
-0.6
-0.4
-0.2
0.0
0.2
meta-regression
hazard
10%
20%
30%
50%
100%
Fig. 2. Variance in telomere length does not decrease with age in humans. Plot-
ted  are the 29 estimates (across 16,384 subjects) of standard deviation of telomere
length collected against the mean age of the subjects in each study. Bubble area
represents the inverse of the sampling variance, the precision of a study, which
is  a function of sample size. Please refer to the supplementary material for the
full  dataset used. The bold line refers to the meta-regression and the closed dots
with associated standard errors represent the meta-analysed standard deviation
for  young versus old subjects. Predicted reductions in variance from the simulations
(see text) are plotted for a continuous hazard and for different proportions dying
from telomere-related causes, as indicated.
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might be better spent on investigating the factors that contribute
to differences in the rate of telomere shortening or the initial vari-
ance of telomere length at birth (Broer et al., 2013; Hjelmborghis cut-off will generate a strong reduction in the variance
n telomere length with age. Note, that due to this cut-off the
eduction in variance is substantially stronger than a continu-
us association of mortality risk with telomere length. The crucial
istinction here is whether individuals actually die from having
ritically shortened telomeres or whether there is an association
etween telomere length and mortality that is not causal.
To illustrate these predicted decline I simulated the predicted
ecline in variance in telomere length due to mortality from age 40
nwards using USA mortality records from 2005 to 2009 (Human
ortality Database, 2014), under two scenarios. In the ﬁrst sce-
ario, an association of telomere length with age-related mortality
isk is modelled using the mean hazard ratio across studies from a
ecent meta-analysis (Boonekamp et al., 2013), and this generated
nly a very shallow, negligible, decrease in the variance of telomere
ength (Fig. 2). In the second scenario, I modelled a causal relation-
hip between short telomeres and mortality risk, such that only the
0% of individuals with the shortest telomeres were at risk of dying
rom telomere-related causes. I simulated this under differential
ractions of mortality caused by telomeres, ranging from 100% to
0%. The model predicts declines in the variance of telomere length
cross this whole range (Fig. 2). The results from these simulations
re dependent on there being limited variation in telomere shorten-
ng amongst individuals and this assumption is supported by recent
arge studies (Benetos et al., 2013; Daniali et al., 2013; Ehrlenbach
t al., 2009). The results also depend on the assumed initial vari-
tion in telomere length; I based my  estimate of this variation on
he overall standard deviation estimated in the meta-analysis (see
elow). I subsequently tested for these predicted declines in vari-Please cite this article in press as: Simons, M.J.P., Questioning caus
http://dx.doi.org/10.1016/j.arr.2015.08.002
nce using a meta-analysis. PRESS
eviews xxx (2015) xxx–xxx
2.2.3. A meta-analysis: variance in telomere length does not
decline with age in humans
For the meta-analysis, I collected data on standard deviation
from a large meta-analysis on sex differences in telomere length
in the general population (Gardner et al., 2014) and I enriched this
set with data from two other recent meta-analyses (Boonekamp
et al., 2013; Müezzinler et al., 2013). I selected samples from which
the age at sampling was  on average over 45 years, after which age-
related mortality occurs. Moreover, I restricted the data to include
only studies that used terminal restriction fragment (TRF) analysis
(southern blotting) (Kimura et al., 2010). TRF analysis is the only
method in which the means and standard deviations can be reliably
compared between laboratories, because it uses a single standard
across laboratories (a DNA molecular weight ladder) to calculate
the mean telomere length per individual (Verhulst et al., 2015).
However when I analysed the available data on qPCR, the other
main method used to measure telomere length, the conclusions
below did not change.
Data were analysed using the natural logarithm of the reported
standard deviation of telomere length, for which the sampling vari-
ance is known to be a function of sample size (Nakagawa et al.,
2014), in a mixed model setting (with study included as random
term) using the R package metafor (Viechtbauer, 2010). Separate
models were ﬁtted that also included covariates such as sex, the
natural logarithm of mean telomere length (Nakagawa et al., 2014),
the standard deviation of subject age in the study, and any combi-
nation of these. In none of these models did variance signiﬁcantly
decrease with age and, in general, the estimated slope was pos-
itive rather than negative (slope of age without any covariates:
0.0015 ± 0.0036 (s.e.), p = 0.68). The predicted reductions in the
variance of telomere length are, however, not linear but depend
on the increase in mortality with age (Fig. 2). The quadratic term
for age, however, was also close to zero and far from signiﬁcant
(−0.0001 ± 0.0003, p = 0.69). Because there were no studies with
mean ages between 59 and 71 years, the data could also be objec-
tively dichotomised between young (<60 years) and old (>70 years).
These two categories did not differ in telomere variance (differ-
ence 0.055 ± 0.095, p = 0.56), corroborating earlier analyses. These
results, and earlier epidemiological evidence (Boonekamp et al.,
2013), therefore suggest that telomere length is not a determinant
of aging but rather a marker able to explain life expectancy and
disease risk, for currently unknown mechanistic reasons.
3. Telomere length in the study of aging
The suggestion that telomeres are not causally involved in the
aging process does not render telomere biology any less interest-
ing. Assumptions of causality from correlational data or the, to date,
restricted number of in vivo mechanistic tests (López-Otín et al.,
2013), could, however, hinder progress in understanding telom-
ere biology and mechanisms of aging in general. Inferring causality
from current knowledge discourages further critical mechanis-
tic experiments to test for causality and, potentially even more
damaging, can lead to false conclusions concerning the biologi-
cal signiﬁcance of associations with telomere length. For example,
interpreting associations of telomere length with lifestyle or detri-
mental psychological events as being associations with cellular
senescence is potentially misleading.
Assuming the causality of telomeres in the biology of aging
can also limit our understanding of the actual core mechanisms
of aging. Investments in ﬁnding ways to elongate telomeres in vivoal involvement of telomeres in aging. Ageing Res. Rev. (2015),
et al., 2015). The latter is especially interesting, considering that
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t might represent variation in telomere shortening in early life,
ith relatively constant telomere loss thereafter (Benetos et al.,
013; Daniali et al., 2013; Ehrlenbach et al., 2009). This would also
xplain why telomere length in early life is most predictive of life
xpectancy (Boonekamp et al., 2013; Heidinger et al., 2012), and ﬁts
ith observations that events in early life have long-lasting effects
Tarry-Adkins and Ozanne, 2011), for which telomeres might then
e a marker (Entringer et al., 2011).
Note that most studies in telomere biology, including most of
hose covered here, use mean telomere length of a cell or a popula-
ion of cells. Whereas it has been suggested that a single critically
hort telomere in a cell can induce cellular senescence, poten-
ially contributing to organismal senescence (Abdallah et al., 2009;
endix et al., 2010; Hemann et al., 2001; Vera et al., 2012). There
s considerable heterogeneity in telomere length across chromo-
omes and cells during ageing as was shown by the use of single
elomere length analysis (STELA) (Baird et al., 2003; Kimura et al.,
007; Lin et al., 2014). Evidence from in vitro studies do suggest
hat such heterogeneity determines cellular senescence (Bendix
t al., 2010; Hemann et al., 2001). It remains to be determined
owever whether in vivo the amount of critically short telomeres
s a better predictor of aging-related mortality. Moreover, if this
s the case, whether this is due to increased measurement preci-
ion of STELA (Martin-Ruiz et al., 2014; Verhulst et al., 2015) or
ecause the measurement of single telomere lengths is closer to
he actual mechanism determining senescence. In a study using
nother method of telomere measurement, ﬂow FISH, variance
f (median) telomere length did decrease with age (Halaschek-
iener et al., 2008), in contrast with the presented meta-analysis,
ut with a markedly lower sample size of 181 compared to a
otal of 16,384 subjects in the meta-analysis presented here (see
upplementary data). Note also that ﬂow FISH is a relative mea-
ure, as qPCR, standardised to a single reference sample of know
ength, precluding quantitative comparisons of variances in telom-
re length between studies.
. Conclusions
Telomere length is attractive as an integrative measure of
omatic damage or past cell replication history, and can there-
ore provide an excellent way to further understand the core
echanisms of aging and early-life programming. The associations
etween telomere length and age-related disease and mortality
hould therefore inspire further research unravelling the factors
ontributing to between-individual differences in telomere length.
uch studies can focus on mechanism, but, as also demonstrated in
his paper, re-appreciation of epidemiological data has the poten-
ial to provide important new insights into the physiological in vivo
unctions of telomere length.
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